FDA Approves First Treatment for Allergic Fungal Rhinosinusitis
The FDA has approved dupilumab (Dupixent) for the treatment of allergic fungal rhinosinusitis (AFRS), marking the first approved therapy for this condition. The approval applies to adults and children aged…